BioCentury
ARTICLE | Clinical News

Lucanix: Phase III amended

November 16, 2009 8:00 AM UTC

NovaRx said FDA approved an amended SPA for the ongoing double-blind, international Phase III STOP trial evaluating best supportive care plus monthly intradermal injections of Lucanix or placebo. The ...